Hep C - Nursing Case Study
Pathophysiology
• Primary mechanism: Hepatitis C virus (HCV) infiltration leads to hepatocyte infection, causing immune-mediated inflammation and liver cell apoptosis. This chronic inflammation fosters fibrotic changes and cirrhosis over time.
• Secondary mechanism: HCV-induced oxidative stress disrupts normal cellular processes, promoting hepatic stellate cell activation. This results in excessive extracellular matrix deposition, further advancing fibrosis.
• Key complication: Progressive liver damage can culminate in hepatocellular carcinoma (HCC), as genetic mutations and cellular dysregulation predispose to malignant transformation.
Patient Profile
Demographics:
58-year-old male, former intravenous drug user
History:
• Key past medical history: Chronic Hepatitis C infection, cirrhosis, type 2 diabetes mellitus, hypertension, substance use disorder (in remission)
• Current medications: Sofosbuvir/Velpatasvir, Metformin, Lisinopril, Propranolol, Lactulose, Spironolactone
• Allergies: Penicillin (rash)
Current Presentation:
• Chief complaint: Severe abdominal pain and swelling
• Key symptoms: Jaundice, ascites, confusion, fatigue, peripheral edema
• Vital signs: Temperature 101.4°F, Heart rate 115 bpm, Blood pressure 85/60 mmHg, Respiratory rate 24 breaths per minute, Oxygen saturation 89% on room air
Section 1
As the nursing team conducts an initial assessment, it becomes evident that the patient's condition is deteriorating. The physical examination reveals significant abdominal distension consistent with ascites, and the presence of a fluid wave suggests severe fluid accumulation. His skin and sclera are markedly jaundiced, and he exhibits spider angiomas on his chest. The patient's mental status is concerning; he demonstrates disorientation to time and place and has difficulty following simple commands, indicating potential hepatic encephalopathy. Breath sounds are diminished at the bases, and there is dullness to percussion, suggesting pleural effusion secondary to cirrhosis.
Laboratory results further complicate the clinical picture. Liver function tests reveal elevated bilirubin at 4.8 mg/dL, AST at 132 U/L, and ALT at 98 U/L, indicating significant hepatic dysfunction. The INR is prolonged at 2.1, and the albumin level is low at 2.3 g/dL, reflecting impaired synthetic function of the liver. Renal function is also compromised, with a creatinine level of 2.1 mg/dL, suggestive of hepatorenal syndrome. The complete blood count shows leukocytosis with a white blood cell count of 14,000/mm³, raising suspicion for spontaneous bacterial peritonitis (SBP). Given the patient's fever and abdominal pain, paracentesis is performed, yielding cloudy ascitic fluid with an elevated white cell count predominantly consisting of neutrophils.
This combination of findings demands rapid intervention and advanced clinical reasoning. The team must prioritize addressing the potential SBP, given its life-threatening nature, while simultaneously managing the other complications of liver failure. The patient's hypotension and tachycardia necessitate careful fluid management to avoid exacerbating ascites or precipitating further renal impairment. The clinical team must also consider the need for adjustments in medication dosing due to altered hepatic and renal clearance. This complex interplay of complications requires a multidisciplinary approach, involving hepatology, nephrology, and critical care, to optimize the patient's outcomes and chart the next steps in his care journey.
Section 2
As the clinical team initiates treatment, focused on stabilizing the patient and managing the complications of liver failure, a new complication emerges that alters the trajectory of care. Despite starting broad-spectrum antibiotics to address the suspected spontaneous bacterial peritonitis, the patient develops increasing respiratory distress. His oxygen saturation, previously maintained at 92% on 2 liters of nasal cannula, has dropped to 86%, necessitating escalation to high-flow oxygen. The patient's respiratory rate is now elevated at 28 breaths per minute, and he exhibits accessory muscle use, indicating significant respiratory compromise.
A stat chest X-ray reveals worsening bilateral pleural effusions, with the right side more pronounced. Additionally, there is evidence of pulmonary edema, likely exacerbated by the rapid fluid shifts and compromised cardiac function secondary to the patient's advanced liver disease. An arterial blood gas shows a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 60 mmHg, indicating acute respiratory acidosis with hypoxemia. The team must urgently address this new development, balancing the need for diuresis to reduce fluid overload with the risk of further renal impairment.
Given these findings, the team decides to initiate a trial of non-invasive ventilation to support the patient's breathing while carefully titrating diuretics to reduce fluid burden without compromising renal perfusion. Concurrently, a consultation with the cardiology team is requested to assess for potential cardiomyopathy or other cardiac issues contributing to the pulmonary edema. These developments necessitate reevaluation of the patient's medication regimen, with consideration of altering doses or discontinuing nephrotoxic agents. The patient's complex presentation underscores the need for vigilant monitoring and dynamic adjustment of the treatment plan, emphasizing the critical interplay between liver, renal, and pulmonary systems in the context of advanced hepatic decompensation.
Section 3
As the clinical team implements non-invasive ventilation and carefully administers diuretics, they closely monitor the patient's response to these interventions. Over the next few hours, the patient's respiratory status shows some improvement; his oxygen saturation rises to 90% with high-flow oxygen, and his respiratory rate decreases slightly to 24 breaths per minute. However, despite these initial positive changes, the patient begins to exhibit signs of altered mental status, becoming increasingly lethargic and disoriented. A repeat arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 62 mmHg, indicating a worsening of respiratory acidosis.
In conjunction with these findings, the patient's lab results show significant elevations in serum creatinine and blood urea nitrogen, suggesting acute kidney injury likely exacerbated by the diuretic therapy and underlying hepatorenal syndrome. The team is now faced with the challenge of managing the delicate balance between effective fluid removal and maintaining renal perfusion. Additionally, a transthoracic echocardiogram conducted by the cardiology team reveals a reduced ejection fraction, confirming the presence of cardiomyopathy, which is contributing to the patient's pulmonary edema and fluid overload.
These developments necessitate an urgent multidisciplinary discussion to reassess the treatment strategy. The team considers the initiation of renal replacement therapy to address the acute kidney injury while continuing to support the patient's respiratory function. The potential need for escalation to invasive mechanical ventilation is also on the table, given the patient's persistent respiratory acidosis and declining mental status. This complex interplay of systems underscores the gravity of the patient's condition and the critical need for coordinated care to navigate the evolving challenges of his hepatic decompensation and multi-organ dysfunction.
Section 4
As the team deliberates on the best course of action, the patient suddenly develops tachycardia with a heart rate of 130 beats per minute and blood pressure drops to 88/54 mmHg, indicating hemodynamic instability. Concurrently, the patient's skin becomes clammy, and jugular venous distention is noted upon examination, suggesting a potential exacerbation of the cardiomyopathy. An urgent electrocardiogram (ECG) is performed, revealing new-onset atrial fibrillation, which is likely further compromising cardiac output and contributing to the hemodynamic compromise.
In light of these new findings, the team opts to administer a cautious dose of intravenous amiodarone to address the atrial fibrillation while monitoring for potential hepatotoxicity, given the patient's hepatic dysfunction. Meanwhile, the nephrology consult recommends emergent initiation of continuous renal replacement therapy (CRRT) to manage fluid overload and acute kidney injury, providing a more controlled approach to fluid removal that may aid in stabilizing the patient's blood pressure and electrolyte balance. The critical care team intensifies monitoring of the patient's neurological status, as the altered mental state may be compounded by hepatic encephalopathy, necessitating adjustments in lactulose dosing and consideration of rifaximin addition.
As these interventions are implemented, the patient's oxygen saturation remains tenuous at 88% with high-flow oxygen, and arterial blood gases show minimal improvement. The persistent respiratory acidosis, compounded by the altered hemodynamic state, prompts the multidisciplinary team to prepare for possible transition to invasive mechanical ventilation. The complexity of managing this patient's multifaceted condition—with hepatic, cardiac, renal, and respiratory challenges—demands ongoing, vigilant reassessment and collaborative decision-making to navigate the precarious balance of interventions and support.
Section 5
As the interdisciplinary team continues to manage the patient's complex condition, a new set of diagnostic results returns, revealing further complications. The latest liver function tests show a significant elevation in bilirubin levels to 6.8 mg/dL, with transaminases markedly increased—AST at 350 U/L and ALT at 420 U/L—indicating worsening hepatic injury. This raises concerns about the potential hepatotoxic effects of the amiodarone, necessitating a delicate balance between controlling the atrial fibrillation and preventing further liver damage. Meanwhile, serum ammonia levels have surged to 120 µmol/L, correlating with the patient's worsening confusion and agitation, strongly suggestive of progressing hepatic encephalopathy.
Simultaneously, the patient's renal status deteriorates with the latest lab results showing rising creatinine levels at 3.2 mg/dL and blood urea nitrogen (BUN) at 58 mg/dL, despite the initiation of CRRT. Electrolyte imbalances persist, with potassium decreasing to 3.0 mEq/L, raising the risk for further cardiac arrhythmias. The team must now weigh the risks and benefits of adjusting the CRRT settings to more aggressively manage the fluid and electrolyte disturbances without precipitating hemodynamic instability.
In response to these developments, the multidisciplinary team convenes another urgent meeting to reassess the treatment strategy. The hepatology team recommends adjusting the lactulose dose to optimize ammonia clearance and plans to initiate rifaximin to target gut flora contributing to the encephalopathy. The cardiology team is exploring alternative anti-arrhythmic options that carry a lower risk of hepatotoxicity, while nephrology continues to refine the CRRT regimen. Throughout these adjustments, the critical care team remains on high alert for any signs of further deterioration, ready to escalate to invasive mechanical ventilation as the patient's respiratory status remains precarious, with arterial blood gases showing a persistent pH of 7.28 and PaCO2 of 58 mmHg. This intricate dance of interventions underscores the critical need for precise clinical judgment and seamless collaboration across specialties to steer the patient towards stabilization.